A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity
Authors:
Open Access
- 6 July 1999
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 96 (14) , 8150-8155
Abstract
NAD(P)H:quinone oxidoreductase 1 (NQO1) is a two-electron reductase that detoxifies quinones derived from the oxidation of phenolic metabolites of benzene. A polymorphism in NQO1, a C609T substitution, has been identified, and individuals homozygous for this change (T/T) have no detectable NQO1. Exposed workers with a T/T genotype have an increased risk of benzene hematotoxicity. This finding suggests NQO1 is protective against benzene toxicity, which is difficult to reconcile with the lack of detectable NQO1 in human bone marrow. The human promyeloblastic cell line, KG-1a, was used to investigate the ability of the benzene metabolite hydroquinone (HQ) to induce NQO1. A concentration-dependent induction of NQO1 protein and activity was observed in KG-1a cells cultured with HQ. Multiple detoxification systems, including NQO1 and glutathione protect against benzene metabolite-induced toxicity. Indeed, exposure to a noncytotoxic concentration of HQ induced both NQO1 and soluble thiols and protected against HQ-induced apoptosis. NQO1 protein and activity increased in wild-type human bone marrow cells (C/C) exposed to HQ, whereas no NQO1 was induced by HQ in bone marrow cells with the T/T genotype. Intermediate induction of NQO1 by HQ was observed in heterozygous bone marrow cells (C/T). NQO1 also was induced by HQ in wild-type (C/C) human bone marrow CD34 + progenitor cells. Our data suggest that failure to induce functional NQO1 may contribute to the increased risk of benzene poisoning in individuals homozygous for the NQO1 C609T substitution (T/T).Keywords
This publication has 72 references indexed in Scilit:
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997
- Inhibition of 1,2,4-benzenetriol-generated active oxygen species and induction of phase II enzymes by green tea polyphenolsChemico-Biological Interactions, 1995
- Differences in xenobiotic detoxifying activities between bone marrow stromal cells from mice and rats: Implications for benzene‐induced hematotoxicityJournal of Toxicology and Environmental Health, 1995
- Characterization of quinone reductase, glutathione and glutathione s-transferase in human myeloid cell lines: Induction by 1,2-dithiole-3-thione and effects on hydroquinone- induced cytotoxicityLife Sciences, 1994
- Metabolism and cytotoxicity of trans,trans-Muconaldehyde and its derivatives: Potential markers of benzene ring cleavage reactionsChemico-Biological Interactions, 1993
- Induction of quinone reductase and glutathione in bone marrow cells by 1,2-dithiole-3-thione: Effect on hydroquinone-induced cytotoxicityToxicology and Applied Pharmacology, 1992
- Activation And Deactivation Of Quinones Catalyzed By Dt-Diaphorase. Evidence For Bioreductive Activation Of Diaziquone (Azq) In Human Tumor Cells And Detoxification Of Benzene Metabolites In Bone Marrow StromaFree Radical Research Communications, 1990
- Reductive addition of glutathione to p-benzoquinone, 2-hydroxy-p-benzoquinone, and p-benzoquinone epoxides. Effect of the hydroxy- and glutathionyl substituents on p-benzohydroquinone autoxidationChemico-Biological Interactions, 1988
- Modulation of stromal cell function in DBA/2J and B6C3F1 mice exposed to benzene or phenolToxicology and Applied Pharmacology, 1985
- Acute Nonlymphocytic LeukemiaNew England Journal of Medicine, 1979